• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎中的心律失常:呼吁组建多学科团队。

Arrhythmias in Rheumatoid Arthritis: A Call for a Multidisciplinary Team.

作者信息

Ungurean Veronica, Costan Diana Elena, Dobos Monica Claudia, Ouatu Anca, Morariu Paula Cristina, Oancea Alexandru Florinel, Godun Maria Mihaela, Floria Diana-Elena, Marcu Dragos Traian, Baroi Genoveva Livia, Stanciu Silviu Marcel, Knieling Anton, Tanase Daniela Maria, Ancuta Codrina, Floria Mariana

机构信息

Department of Medical Sciences II, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.

Department of Rheumatology, Clinic Rehabilitation Hospital, 700661 Iasi, Romania.

出版信息

Life (Basel). 2025 Sep 11;15(9):1426. doi: 10.3390/life15091426.

DOI:10.3390/life15091426
PMID:41010368
Abstract

BACKGROUND

Rheumatoid arthritis is the most prevalent systemic inflammatory disease, mainly affecting the synovial tissue of small and large joints, also associated with significant extra-articular manifestations. Throughout the progression of the disease, cardiac structures may be affected, including the conducting system, myocardium, endocardium, coronary arteries, and valves, potentially resulting in a higher incidence of cardiac arrhythmias.

METHODS

We performed a narrative review of the most recent studies that highlight the epidemiology, pathophysiology, diagnosis, and management of arrhythmias occurring in patients with rheumatoid arthritis. Furthermore, we examined the impact of disease-modifying antirheumatic drugs (DMARDs)-including conventional synthetic (csDMARDs), biologic (bDMARDs), and targeted synthetic agents (tsDMARDs)-on cardiac electrophysiology.

RESULTS

Cardiac immune cells may influence arrhythmogenesis through non-canonical and inflammatory mechanisms by modifying myocardial tissue architecture or by interacting with cardiomyocytes, potentially altering their electrical function.

CONCLUSIONS

This review emphasizes the essential role of a multidisciplinary approach integrating rheumatology and cardiology expertise in the screening and management of arrhythmias in patients with rheumatoid arthritis.

摘要

背景

类风湿关节炎是最常见的全身性炎症性疾病,主要影响大小关节的滑膜组织,也伴有明显的关节外表现。在疾病的整个进展过程中,心脏结构可能会受到影响,包括传导系统、心肌、心内膜、冠状动脉和瓣膜,这可能导致心律失常的发生率更高。

方法

我们对最近的研究进行了叙述性综述,这些研究突出了类风湿关节炎患者发生心律失常的流行病学、病理生理学、诊断和管理。此外,我们研究了改善病情抗风湿药物(DMARDs)——包括传统合成药物(csDMARDs)、生物制剂(bDMARDs)和靶向合成药物(tsDMARDs)——对心脏电生理的影响。

结果

心脏免疫细胞可能通过非经典和炎症机制影响心律失常的发生,这些机制包括改变心肌组织结构或与心肌细胞相互作用,从而可能改变其电功能。

结论

本综述强调了在类风湿关节炎患者心律失常的筛查和管理中,整合风湿病学和心脏病学专业知识的多学科方法的重要作用。

相似文献

1
Arrhythmias in Rheumatoid Arthritis: A Call for a Multidisciplinary Team.类风湿关节炎中的心律失常:呼吁组建多学科团队。
Life (Basel). 2025 Sep 11;15(9):1426. doi: 10.3390/life15091426.
2
Summary of AHRQ's Comparative Effectiveness Review of Disease-Modifying Antirheumatic Drugs for Children with Juvenile Idiopathic Arthritis.美国医疗保健研究与质量局(AHRQ)对用于青少年特发性关节炎患儿的改善病情抗风湿药的比较效果评价总结。
J Manag Care Pharm. 2012 Jan-Feb;18(1 Suppl B):1-16. doi: 10.18553/jmcp.2012.18.S1-B.1.
3
Shoulder Arthrogram肩关节造影
4
Vesicoureteral Reflux膀胱输尿管反流
5
Improvement in work productivity among psoriatic arthritis patients treated with biologic or targeted synthetic drugs: a systematic literature review and meta-analysis.生物制剂或靶向合成药物治疗银屑病关节炎患者的工作生产力改善:系统文献回顾和荟萃分析。
Arthritis Res Ther. 2024 Feb 15;26(1):50. doi: 10.1186/s13075-024-03282-0.
6
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.阿达木单抗、依那西普、英夫利昔单抗、聚乙二醇化赛妥珠单抗、戈利木单抗、托珠单抗和阿巴西普用于治疗既往未使用改善病情抗风湿药物治疗且仅在传统改善病情抗风湿药物治疗失败后的类风湿关节炎:系统评价和经济学评估。
Health Technol Assess. 2016 Apr;20(35):1-610. doi: 10.3310/hta20350.
7
Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.用于类风湿关节炎贫血的促红细胞生成素
Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD000332. doi: 10.1002/14651858.CD000332.pub3.
8
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
9
Effects of biologic and target synthetic disease-modifying anti-rheumatic drugs on sarcopenia in spondyloarthritis and rheumatoid arthritis: a systematic review and meta-analysis.生物制剂和靶向合成的改善病情抗风湿药物对脊柱关节炎和类风湿关节炎患者肌少症的影响:系统评价和荟萃分析。
Clin Rheumatol. 2023 Apr;42(4):979-997. doi: 10.1007/s10067-022-06454-y. Epub 2022 Dec 3.
10
Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies.影响临床医生为炎症性关节炎开具疾病修正抗风湿药物的因素:系统评价和定性研究的主题综合分析。
Semin Arthritis Rheum. 2022 Aug;55:151988. doi: 10.1016/j.semarthrit.2022.151988. Epub 2022 Feb 27.

本文引用的文献

1
Cardiovascular Outcomes of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Review of the Current Evidence.改善病情抗风湿药物治疗类风湿关节炎的心血管结局:当前证据综述
Cureus. 2025 Apr 14;17(4):e82269. doi: 10.7759/cureus.82269. eCollection 2025 Apr.
2
Cardiovascular safety of Janus kinase inhibitors: A pharmacovigilance study from 2012-2023.Janus激酶抑制剂的心血管安全性:一项2012年至2023年的药物警戒研究。
PLoS One. 2025 May 12;20(5):e0322849. doi: 10.1371/journal.pone.0322849. eCollection 2025.
3
Relationship between epicardial adipose tissue volume and atrial fibrillation in patients with rheumatoid arthritis.
类风湿关节炎患者的心外膜脂肪组织体积与心房颤动之间的关系。
Front Cardiovasc Med. 2025 Apr 9;12:1508025. doi: 10.3389/fcvm.2025.1508025. eCollection 2025.
4
Major adverse cardiovascular, thromboembolic and malignancy events in the filgotinib rheumatoid arthritis and ulcerative colitis clinical development programmes.非戈替尼治疗类风湿性关节炎和溃疡性结肠炎临床研发项目中的主要不良心血管、血栓栓塞和恶性肿瘤事件。
RMD Open. 2025 Mar 4;11(1):e005033. doi: 10.1136/rmdopen-2024-005033.
5
Atrial Fibrillation Recurrence Risk After Catheter Ablation in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.类风湿性关节炎患者导管消融术后房颤复发风险:一项系统评价和荟萃分析
Clin Cardiol. 2025 Jan;48(1):e70021. doi: 10.1002/clc.70021.
6
Prevalence and Risk Factors of Cardiovascular Disease in Rheumatoid Arthritis Patients: A Comparative Analysis of Real-World Data.类风湿关节炎患者心血管疾病的患病率及危险因素:真实世界数据的比较分析
Int J Gen Med. 2024 Dec 6;17:5859-5868. doi: 10.2147/IJGM.S490916. eCollection 2024.
7
Is the development of arrhythmia predictable in rheumatoid arthritis?类风湿关节炎中心律失常的发生是否可预测?
Arch Rheumatol. 2024 Aug 26;39(3):429-435. doi: 10.46497/ArchRheumatol.2024.10590. eCollection 2024 Sep.
8
Efficacy of the cardiac glycoside digoxin as an adjunct to csDMARDs in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled trial.强心苷地高辛作为改善病情抗风湿药物(csDMARDs)辅助药物对类风湿关节炎患者的疗效:一项随机、双盲、安慰剂对照试验。
Front Pharmacol. 2024 Oct 21;15:1445708. doi: 10.3389/fphar.2024.1445708. eCollection 2024.
9
Association of Cardiovascular Outcomes With Low-Dose Glucocorticoid Prescription in Patients With Rheumatoid Arthritis.类风湿关节炎患者低剂量糖皮质激素处方与心血管结局的关联。
Arthritis Rheumatol. 2024 Nov;76(11):1585-1593. doi: 10.1002/art.42928. Epub 2024 Jul 23.
10
Hydroxychloroquine and Chloroquine-Induced Cardiac Arrhythmias and Sudden Cardiac Death in Patients With Systemic Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis.羟氯喹和氯喹引起的系统性自身免疫性风湿病患者的心律失常和心源性猝死:系统评价和荟萃分析。
J Cardiovasc Pharmacol. 2024 Aug 1;84(2):158-169. doi: 10.1097/FJC.0000000000001589.